These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1775149)

  • 21. Phenomenological aspects of monodelusional disorders.
    Munro A
    Br J Psychiatry Suppl; 1991 Nov; (14):62-4. PubMed ID: 1840783
    [No Abstract]   [Full Text] [Related]  

  • 22. Spatial working memory deficits and their relationship to negative symptoms in unmedicated schizophrenia patients.
    Carter C; Robertson L; Nordahl T; Chaderjian M; Kraft L; O'Shora-Celaya L
    Biol Psychiatry; 1996 Nov; 40(9):930-2. PubMed ID: 8896783
    [No Abstract]   [Full Text] [Related]  

  • 23. Electrodermal activity as a prodromal sign in schizophrenia.
    Hazlett H; Dawson ME; Schell AM; Nuechterlein KH
    Biol Psychiatry; 1997 Jan; 41(1):111-3. PubMed ID: 8988801
    [No Abstract]   [Full Text] [Related]  

  • 24. Light exposure patterns in schizophrenia.
    Gerbaldo H; Demisch L; Cardinali DP
    Acta Psychiatr Scand; 1992 Jan; 85(1):94-5. PubMed ID: 1546557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in the electrodermal activity of schizophrenic patients associated with changes in the expressed emotion status of their relatives.
    Tarrier N
    Psychopathology; 1991; 24(4):203-8. PubMed ID: 1754651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between DST nonsuppression and shortened REM latency in schizophrenia.
    Tandon R; Lewis C; Taylor SF; Shipley JE; DeQuardo JR; Jibson M; Goldman M
    Biol Psychiatry; 1996 Oct; 40(7):660-3. PubMed ID: 8886301
    [No Abstract]   [Full Text] [Related]  

  • 27. Dilapidation in schizophrenia: relationship to negative syndrome and prefrontal impairment.
    Merriam AE; Kay SR; Opler LA; Hegarty A
    Psychiatry Res; 1990 Nov; 34(2):221-2. PubMed ID: 2287652
    [No Abstract]   [Full Text] [Related]  

  • 28. Beyond the Kraepelinean dichotomy.
    Wexler BE
    Biol Psychiatry; 1992 Mar; 31(6):539-41. PubMed ID: 1581434
    [No Abstract]   [Full Text] [Related]  

  • 29. A selective review of biological markers in schizophrenia.
    Szymanski S; Kane JM; Lieberman JA
    Schizophr Bull; 1991; 17(1):99-111. PubMed ID: 1675484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Schizophrenia forty-five years later.
    Lawton MP
    J Genet Psychol; 1972 Sep; 121(1st Half):133-43. PubMed ID: 5069755
    [No Abstract]   [Full Text] [Related]  

  • 31. An integrated eye movement score as a neurophysiological marker of schizophrenia.
    Miura K; Hashimoto R; Fujimoto M; Yamamori H; Yasuda Y; Ohi K; Umeda-Yano S; Fukunaga M; Iwase M; Takeda M
    Schizophr Res; 2014 Dec; 160(1-3):228-9. PubMed ID: 25458574
    [No Abstract]   [Full Text] [Related]  

  • 32. Duration of illness and structure of symptoms in schizophrenia.
    Peralta V; Cuesta MJ
    Psychol Med; 2000 Mar; 30(2):481-3. PubMed ID: 10824668
    [No Abstract]   [Full Text] [Related]  

  • 33. Patient self-regulation and functioning in schizophrenia.
    Hamera EK; Peterson KA; Handley SM; Plumlee AA; Frank-Ragan E
    Hosp Community Psychiatry; 1991 Jun; 42(6):630-1. PubMed ID: 1864576
    [No Abstract]   [Full Text] [Related]  

  • 34. Psychophysiology at the interface of clinical science, cognitive science, and neuroscience.
    Dawson ME
    Psychophysiology; 1990 May; 27(3):243-55. PubMed ID: 2236428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Competence of consent and associated factors among inpatients of schizophrenia in Changsha, China.
    Di X; Cheng HG
    Schizophr Res; 2013 Oct; 150(1):325-6. PubMed ID: 23932149
    [No Abstract]   [Full Text] [Related]  

  • 36. Drive theories of schizophrenia.
    Epstein S; Coleman M
    Psychosom Med; 1970; 32(2):113-40. PubMed ID: 4908902
    [No Abstract]   [Full Text] [Related]  

  • 37. Somatic symptoms in schizophrenia.
    Tyler M
    Schizophr Res; 1995 Dec; 18(1):87-8. PubMed ID: 8929767
    [No Abstract]   [Full Text] [Related]  

  • 38. Time judgments by magnitude estimation and magnitude production and anxiety: a problem of comparison between normals and certain schizophrenic patients.
    Rutschmann J
    J Psychol; 1973 Nov; 85(2d Half):187-223. PubMed ID: 4748963
    [No Abstract]   [Full Text] [Related]  

  • 39. Variation in symptom severity over the menstrual cycle of schizophrenics.
    Hallonquist JD; Seeman MV; Lang M; Rector NA
    Biol Psychiatry; 1993 Feb; 33(3):207-9. PubMed ID: 8448269
    [No Abstract]   [Full Text] [Related]  

  • 40. CSF noradrenaline and schizophrenia.
    Kemali D; Maj M
    Am J Psychiatry; 1986 Jan; 143(1):126-7. PubMed ID: 3942277
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.